Oncotarget

Research Papers: Gerotarget (Focus on Aging):

Protease activated receptor-1 regulates macrophage-mediated cellular senescence: a risk for idiopathic pulmonary fibrosis

Cong Lin, Farhad Rezaee, Maaike Waasdorp, Kun Shi, Tom van der Poll, Keren Borensztajn and C. Arnold Spek _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:35304-35314. https://doi.org/10.18632/oncotarget.6095

Metrics: PDF 1135 views  |   HTML 1206 views  |   ?  


Abstract

Cong Lin1, Farhad Rezaee1,2, Maaike Waasdorp1, Kun Shi1, Tom van der Poll1, Keren Borensztajn1,3,4,* and C. Arnold Spek1,*

1 Center for Experimental and Molecular Medicine, Academic Medical Center, Amsterdam, The Netherlands

2 Department of Cell Biology, University Medical Center Groningen, University of Groningen, The Netherlands

3 Inserm UMR1152, Medical School Xavier Bichat, Paris, France

4 Département Hospitalo-universtaire FIRE and LabEx Inflamex, Paris, France

* These authors have contributed equally to this work

Correspondence to:

Farhad Rezaee, email:

Cong Lin, email:

Keywords: protease-activated receptor, pulmonary fibrosis, bleomycin, macrophages, cellular senescence, TGF-β, Gerotarget

Received: August 12, 2015 Accepted: September 24, 2015 Published: October 12, 2015

Abstract

Idiopathic pulmonary fibrosis (IPF) is a destructive disease in part resulting from premature or mature cellular aging. Protease-activated receptor-1 (PAR-1) recently emerged as a critical component in the context of fibrotic lung diseases. Therefore, we aimed to study the role of macrophages in PAR-1-mediated idiopathic pulmonary fibrosis. The number of macrophages were significantly reduced in lungs of PAR-1 antagonist (P1pal-12) treated animals upon bleomycin instillation. In line with these data, PAR-1 stimulation increased monocyte / macrophage recruitment in response to epithelium injury in in vitro trans-well assays. Moreover, macrophages induced fibroblasts migration, differentiation and secretion of collagen, which were inhibited in the presence of TGF-β receptor inhibitors. Interestingly, these profibrotic effects were partially inhibited by treatment with the PAR-1 inhibitor P1pal-12. Using shRNA mediated PAR-1 knock down in fibroblasts, we demonstrate that fibroblast PAR-1 contributes to TGF-β activation and production. Finally, we show that the macrophage-dependent induction of PAR-1 driven TGF-β activation was mediated by FXa. Our data identify novel mechanisms by which PAR-1 stimulation on different cell types can contribute to IPF and identify macrophages as key players in PAR-1 dependent development of this devastating disease. IPF may result from cellular senescence mediated by macrophages in the lung.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 6095